ArticleObesity (Silver Spring, Md.)2023

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program.

Carel W le Roux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.